ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1799

High Fat-Diet as a Catalyst to Lupus Development and Autoimmunity in MRL/lpr Mice

Hiba Ali1, Juan Meng2, Xuhua Shi2, Linh Hellmers3, Swathi Dhulipala4, Patricia Kachur4, Therese Posas-Mendoza4, Robert Quinet5, William Davis5, Jerald Zakem4, Zongbing You2 and Xin Zhang3, 1Dept. of Rheumatology, Ochsner Medical Center, New Orleans, 2Tulane University Health Science Center, New Orleans, 3Institution of Translational Research, Ochsner Medical Center, New Orleans, 4Dept of Rheumatology, Ochsner Medical Center, New Orleans, 5Dept of Rheumatology, Ochsner Medical Center, New Orleans, LA

Meeting: ACR Convergence 2020

Keywords: diet, Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III: Bench to Bedside

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with features of autoantibodies, skin rash, kidney and other multiple organ involvement. Evidence shows that obesity is a major factor contributing to the onset and progression of autoimmune diseases including SLE and is highly linked to their cumulative organ damage. Our previous study and others have shown that circulating T follicular helper (Tfh) cells are implicated in promoting B cells production of autoantibodies and shape the composition of the gut microbiota thus modulating obesity.  In this study, we evaluated the impact of high fat diet (HFD) on the development of SLE and obesity, and the pathophysiologic link of obesity, SLE, and Tfh cells in MRL/lpr lupus prone mice.

Methods: Thirty MRL/lpr mice were fed a regular diet (RD, 10% calories from fat) or high fat diet (HFD, 60% calories from fat) beginning at 2 months of age, half male and half female. Their body weights and skin lesions were recorded weekly. Urine protein was assessed weekly by Bradford assay. Blood was collected monthly for serum IgG, anti-dsDNA antibody, and anti-nuclear antibody (ANA) detection. At week 14, mice were euthanized, their spleen were measured and weighed. Kidney and skin biopsy were embedded in paraffin and tissue sections for H&E, PAS, and Masson’s staining to detect lupus histopathological lesions and quantified as kidney index and histological skin score based on glomerular cellularity, glomerular deposits, interstitial inflammation, and inflammatory dermatitis. Tfh cells (CD4+CXCR5+) were examined in blood and splenic sections by flow cytometry and immunofluorescent staining.

Results: The HFD group induced a significant increase in mouse body weight by week 3 and continued until week 14 compared to RD group (p< 0.05 to p< 0.01). Skin lesions on the dorsum of neck, forehead, and ears in HFD group, resembling human discoid lupus, manifested as earliest as week 6 and occurred in 55.6% of the HFD group vs 11.1% of the RD group (p< 0.05). Splenomegaly was observed in the HFD mice (p< 0.05). Proteinuria was increased from week 11 to week 14 in HFD group. There was an increase trend of anti-dsDNA antibody and serum IgG titer in HFD group, but no difference of ANA was observed between HFD and RD groups. HFD mice also had a higher histological score of skin (p< 0.05) and higher acute and chronic index of kidney than RD mice. Significant increase of CD4+CXCR5+ Tfh cells was observed in both blood and spleen in HFD group mice.

Conclusion: Our results show that a high fat diet induced an accelerated and more severe form of lupus development and autoimmunity in MRL/lpr mice. This indicates that HFD exacerbates the development of SLE. The elevated disease course in HFD mice was accompanied by increased of Tfh cells. Interventions of healthy diet or targeting Tfh cells may improve both lupus symptoms and outcomes in genetically predisposed SLE patients.


Disclosure: H. Ali, None; J. Meng, None; X. Shi, None; L. Hellmers, None; S. Dhulipala, None; P. Kachur, None; T. Posas-Mendoza, None; R. Quinet, None; W. Davis, None; J. Zakem, None; Z. You, None; X. Zhang, None.

To cite this abstract in AMA style:

Ali H, Meng J, Shi X, Hellmers L, Dhulipala S, Kachur P, Posas-Mendoza T, Quinet R, Davis W, Zakem J, You Z, Zhang X. High Fat-Diet as a Catalyst to Lupus Development and Autoimmunity in MRL/lpr Mice [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/high-fat-diet-as-a-catalyst-to-lupus-development-and-autoimmunity-in-mrl-lpr-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-fat-diet-as-a-catalyst-to-lupus-development-and-autoimmunity-in-mrl-lpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology